Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer
signature has a robust predictive performance for prognosis in early-stage breast cancer, but the experiment that reported this relied on public microarray data and fresh-frozen samples. Before signature can be used in a clinical setting, a simple and low-cost diagnostic system using formalin-fixed...
Saved in:
Published in | Oncotarget Vol. 9; no. 18; pp. 14193 - 14206 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Impact Journals LLC
06.03.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!